RESUMO
Abstract The present study was performed to explore the curative effect of Methylsulfonylmethane (MSM) in an experimental model of myoglobinuric acute renal failure (ARF). In this experimental model, Rats were injected with 50% glycerol (10 mL/kg, im) followed by an hour later and daily in the next six days by MSM (400 mg/kg) or saline. Kidney's function (urea and creatinine), and reduced glutathione were analyzed. A renal failure produced by glycerol injection, with a significant increase of blood urea and serum creatinine was observed. Rats that received MSM in addition to glycerol had significantly lower blood urea and serum creatinine levels compared to those receiving glycerol alone. However, glutathione has markedly increased after MSM treatment. The effect is probably due to the antioxidant activity of MSM. This may provide therapeutic opportunities for treating humans, myoglobinuric ARF.
Assuntos
Animais , Masculino , Feminino , Ratos , Compostos de Enxofre/efeitos adversos , Mecanismos Defensivos e Curativos , Insuficiência Renal/induzido quimicamente , Glicerol/agonistas , Glicerol , MioglobinúriaRESUMO
Combative sport is one of the most physically intense forms of exercise, yet the effect of recovery interventions has been largely unexplored. We investigated the effect of cold-water immersion on structural, inflammatory, and physiological stress biomarkers following a mixed martial arts (MMA) contest preparation training session in comparison with passive recovery. Semiprofessional MMA competitors (n = 15) were randomly assigned to a cold-water immersion (15 min at 10 °C) or passive recovery protocol (ambient air) completed immediately following a contest preparation training session. Markers of muscle damage (urinary myoglobin), inflammation/oxidative stress (urinary neopterin + total neopterin (neopterin + 7,8-dihydroneopterin)), and hypothalamic-pituitary axis (HPA) activation (saliva cortisol) were determined before, immediately after, and 1, 2, and 24 h postsession. Ratings of perceived soreness and fatigue, counter movement jump, and gastrointestinal temperature were also measured. Concentrations of all biomarkers increased significantly (p < 0.05) postsession. Cold water immersion attenuated increases in urinary neopterin (p < 0.05, d = 0.58), total neopterin (p < 0.05, d = 0.89), and saliva cortisol after 2 h (p < 0.05, d = 0.68) and urinary neopterin again at 24 h (p < 0.01, d = 0.57) in comparison with passive recovery. Perceived soreness, fatigue, and gastrointestinal temperatures were also lower for the cold-water immersion group at several time points postsession whilst counter movement jump did not differ. Combative sport athletes who are subjected to impact-induced stress may benefit from immediate cold-water immersion as a simple recovery intervention that reduces delayed onset muscle soreness as well as macrophage and HPA activation whilst not impairing functional performance.
Assuntos
Temperatura Baixa , Exercício Físico , Imersão , Artes Marciais , Adulto , Fadiga/fisiopatologia , Humanos , Hidrocortisona/química , Hidrocortisona/urina , Masculino , Músculo Esquelético/fisiologia , Mialgia/fisiopatologia , Mioglobina/metabolismo , Mioglobinúria , Neopterina/urina , Saliva/química , Adulto JovemRESUMO
Myoglobinuric acute renal failure (MARF) may develop after severe muscle injury. Heme oxygenase-1 (HO-1), a stress-response protein, has been implicated as a protective agent against MARF. We hypothesized that hyperbaric oxygen therapy (HBOT) may alleviate MARF by inducing renal HO-1 expression. Wistar-Albino rats were randomly assigned into three groups: Control (n = 4), MARF (n = 8), MARF + HBO (n = 8). MARF was induced by intramuscular glycerol (50%, 8 mL/kg) injection. Saline (8 mL/kg) was injected into the hind limb of the animals in the control group. Animals in the MARF + HBO group received two sessions of HBO therapy (90 min at 2.5 atm) 2 and 18 h after glycerol injection. Serum and tissue samples were taken at 24 h. Serum urea and creatinine levels increased in the MARF and MARF + HBO groups confirming the development of MARF. But, serum urea and creatinine levels were similar in MARF and MARF + HBO groups. Oxidative stress parameters were similar among all groups. Histological renal injury score was similar in MARF and MARF + HBO groups. HO-1 level, determined by immunohistochemistry, was significantly higher in MARF and MARF + HBO groups, compared to the control group. Although HO-1 level in MARF + HBO group was higher than MARF group, it was not statistically significant. We found that HBOT did not reduce renal injury in experimental MARF model. HBOT is used to reduce the muscle damage after crush injury, which may be accompanied by MARF. Therefore, more studies are needed to understand the effects of HBO treatment on renal functions after MARF.
Assuntos
Injúria Renal Aguda/terapia , Creatinina/metabolismo , Oxigenoterapia Hiperbárica/métodos , Mioglobinúria/complicações , Rabdomiólise/complicações , Superóxido Dismutase/metabolismo , Injúria Renal Aguda/etiologia , Injúria Renal Aguda/metabolismo , Animais , Nitrogênio da Ureia Sanguínea , Modelos Animais de Doenças , Testes de Função Renal , Masculino , Mioglobinúria/diagnóstico , Mioglobinúria/metabolismo , Estresse Oxidativo , Ratos , Ratos Wistar , Rabdomiólise/diagnósticoRESUMO
Los ácidos grasos representan el 80% de las necesidades energéticas en periodos de estrés metabólico. La betaoxidación de los ácidos grasos es catalizada por varias enzimas, como la acil-CoA deshidrogenasa-coenzima FAD, que posee 4 formas específicas según la longitud de la cadena de acil-CoA. La acil-CoA-deshidrogenasa de cadena muy larga es una de ellas. Su déficit cursa con la acumulación intramitocondrial de ésteres de acil-CoA de cadena larga, y afecta al corazón, el músculo esquelético y el hígado. Presentamos un caso iniciado a los 22 meses de edad con un síndrome Reye-like. Confirmamos un déficit de la betaoxidación de los ácidos grasos de cadena muy larga, con las mutaciones p.A232T (c.694G>A) y p.Y201C (c.602A>G) en los alelos del gen VLCAD. Describimos su evolución durante 17 años recibiendo una dieta pobre en ácidos grasos de cadena larga y suplementos con aceite MCT (AU)
Fatty acids represent 80% of energy needs during periods of stress. Beta-oxidation of fatty acids is catalyzed by some enzymes including acyl-CoA-dehydrogenase-coenzyme FAD, wich has four different ways according to the chain length of acyl-CoA. The very-long-chain-acyl-CoA-dehydrogenase is one of them. A deficiency of this enzyme produces an accumulation of long-chain-acyl-CoA-esters in mitochondrias, affecting heart, skeletal muscle and liver. We report the case of a 22-month aged child whose first symptom was a Reye-like syndrome. We confirmed that he was affected by a deficiency in the beta-oxidation of fatty acids of very long chain. He showed some mutations in the VLCAD gene alleles: p.A232T (c.694G>A) and p.Y201C (c.602A>G). We explain the evolution in the next 17 years, following a diet with very little long chain fatty acids and MCT oil supplements (AU)
Assuntos
Humanos , Masculino , Lactente , Acil-CoA Desidrogenases/deficiência , Síndrome de Reye/diagnóstico , Hipoglicemia/diagnóstico , Encefalopatia Hepática/diagnóstico , Cardiomiopatia Hipertrófica/diagnóstico , Ácidos Graxos/metabolismo , Rabdomiólise/complicações , Mioglobinúria/complicações , Programas de Rastreamento/métodos , Espectrometria de Massas em Tandem , Hipotonia Muscular/complicaçõesRESUMO
Exertional rhabdomyolysis is an enigmatic syndrome with multiple risk factors and a wide spectrum of clinical outcomes. Dietary supplements containing caffeine may potentiate the rhabdomyolysis cascade, and present an area of attainable prevention. Presented are three cases of soldiers using the weight loss supplement brand, Hydroxycut; patient education regarding caffeine and supplement safety may shield against morbidity and delayed soldier readiness associated with overcaffeination.
Assuntos
Suplementos Nutricionais/efeitos adversos , Militares , Esforço Físico , Preparações de Plantas/efeitos adversos , Rabdomiólise/etiologia , Adulto , Creatina Quinase/sangue , Humanos , Masculino , Mioglobinúria/etiologia , Rabdomiólise/sangue , Rabdomiólise/urina , Estados Unidos , Adulto JovemRESUMO
Myoglobinuric acute renal failure (ARF) is a uremic syndrome caused by traumatic or non-traumatic skeletal muscle breakdown and intracellular elements that are released into the bloodstream. We hypothesized that hyperbaric oxygen (HBO) therapy could be beneficial in the treatment of myoglobinuric ARF caused by rhabdomyolysis. A total of 32 rats were used in the study. The rats were divided into four groups: control, control+hyperbaric oxygen (control+HBO), ARF, and ARF+hyperbaric oxygen (ARF+HBO). Glycerol (8 ml/kg) was injected into the hind legs of each of the rats in ARF and ARF+HBO groups. 2.5 atmospheric absolute HBO was applied to the rats in the control+HBO and ARF+HBO groups for 90 min on two consecutive days. Plasma urea, creatinine, sodium, potassium, calcium, aspartate aminotransferase, alanine aminotransferase, lactic dehydrogenase, creatinine kinase and urine creatinine and sodium were examined. Creatinine clearance and fractional sodium excretion could then be calculated. Superoxide dismutase, catalase, glutathione and malondialdehyde (MDA) levels were assessed in renal tissue. Tissue samples were evaluated by Hematoxylin-eosin, PCNA and TUNEL staining histopathologically. MDA levels were found to be significantly decreased whereas SOD and CAT were twofold higher in the ARF+HBO group compared to the ARF group. Renal function tests were ameliorated by HBO therapy. Semiquantitative evaluation of histopathological findings indicated that necrosis and cast formation was decreased by HBO therapy and TUNEL staining showed that apoptosis was inhibited. PCNA staining showed that HBO therapy did not increase regeneration. Ultimately, we conclude that, in accordance with our hypothesis, HBO could be beneficial in the treatment of myoglobinuric ARF.
Assuntos
Injúria Renal Aguda/prevenção & controle , Oxigenoterapia Hiperbárica , Mioglobinúria/prevenção & controle , Oxigênio/uso terapêutico , Rabdomiólise/prevenção & controle , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/metabolismo , Animais , Catalase/metabolismo , Creatinina/metabolismo , Glutationa/metabolismo , Glicerol/toxicidade , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Testes de Função Renal , Peroxidação de Lipídeos , Masculino , Malondialdeído/metabolismo , Mioglobinúria/induzido quimicamente , Mioglobinúria/metabolismo , Oxirredução , Ratos , Ratos Sprague-Dawley , Rabdomiólise/induzido quimicamente , Rabdomiólise/metabolismo , Superóxido Dismutase/metabolismoRESUMO
INTRODUCTION: This case report describes a patient who developed rhabdomyolysis temporally associated with the use of a mislabeled acai berry dietary supplement. METHODS AND RESULTS: The authors describe a 22-year-old man presenting with rhabdomyolysis approximately 2 weeks after starting a weight-loss dietary supplement. His medical history was significant only for hypertension treated with amlodipine. The diagnosis of rhabdomyolysis was confirmed (creatine kinase, 84,000 IU/L, positive urine myoglobin) with other potential causes ruled out. The signs and symptoms of the patient gradually resolved and he was discharged on hospital day 5. Assessment using the Naranjo Adverse Drug Reaction Probability Scale yielded a score of 3, indicating a possible relationship between the supplement and rhabdomyolysis. Although the product was labeled and promoted as containing acai berry and additional ingredients, there was no acai berry found on analysis. CONCLUSION: Clinicians should be aware that all dietary supplements may vary in uniformity and contain unknown contaminants.
Assuntos
Arecaceae/efeitos adversos , Suplementos Nutricionais/efeitos adversos , Rotulagem de Medicamentos , Preparações de Plantas/efeitos adversos , Rabdomiólise/induzido quimicamente , Rabdomiólise/diagnóstico , Arecaceae/química , Creatina Quinase/sangue , Diagnóstico Diferencial , Suplementos Nutricionais/análise , Humanos , Masculino , Mississippi , Mioglobinúria , Preparações de Plantas/análise , Rabdomiólise/terapia , Resultado do Tratamento , Adulto JovemRESUMO
An NCAA football player developed an acute paraspinal compartment syndrome after a weight-lifting strain. The patient presented with myonecrosis (CK up to 77,400 U/L), and myoglobinuria. Treatment consisted of forced diuresis and six sessions in the hyperbaric oxygen chamber.
Assuntos
Síndromes Compartimentais/terapia , Oxigenoterapia Hiperbárica , Esforço Físico , Síndromes Compartimentais/sangue , Síndromes Compartimentais/complicações , Creatina Quinase/sangue , Diurese , Humanos , Dor Lombar/etiologia , Masculino , Mioglobinúria/etiologia , Resultado do Tratamento , Adulto JovemRESUMO
Quail poisoning is known to produce an acute myoglobinuric syndrome called coturnism. The cause of this syndrome is still unknown, although it has been postulated that Galeopsis ladanum L. seeds, in particular lipidic compounds or stachydrine, are responsible for this toxicity. Thus, we aimed to study the implication of this plant in coturnism in order to explore the physiopathology of the disease, especially with regard to stachydrine and lipidic compounds extracted from seeds. For this purpose, Wistar rats were fed with G. ladanum seed extracts or with quail meat. However, the rhabdomyolysis outbreak could not be reproduced in any case. Therefore, in view of our results and experimental conditions, seeds of G. ladanum and stachydrine do not appear to be the responsible agents of the myopathic outbreak. This conclusion is supported by the following facts: direct administration of extracts of seeds of G. ladanum or stachydrine produces no myotoxicity in rats; G. ladanum seeds are not toxic to quails and meat from quails fed G. ladanum seeds is not toxic to rats.
Assuntos
Lamiaceae , Carne/toxicidade , Doenças Musculares/induzido quimicamente , Prolina/análogos & derivados , Codorniz , Sementes/toxicidade , Animais , Dieta , Humanos , Masculino , Debilidade Muscular , Doenças Musculares/etiologia , Mioglobinúria/induzido quimicamente , Mioglobinúria/etiologia , Extratos Vegetais/toxicidade , Prolina/toxicidade , Ratos , Ratos Wistar , Rabdomiólise/induzido quimicamente , Rabdomiólise/etiologia , Sementes/químicaRESUMO
There is increasing evidence indicating that oxidative stress plays an important role in the pathogenesis of rhabdomyolysis-induced myoglobinuric acute renal failure (ARF). During times of war and natural disasters, myoglobinuric ARF can assume epidemic proportions. Thus, early and effective renoprotective treatments are of utmost importance. It has been shown that L-carnitine, used as a safe and effective nutritional supplement for more than three decades, is effective in preventing renal injury in many renal injury models involving oxidative stress. The present study was performed to investigate the effects of L-carnitine in an experimental model of myoglobinuric ARF. Four groups of rats were employed in this study: group 1 served as a control; group 2 was given glycerol (10 mL/kg, i.m.); group 3 was given glycerol plus L-carnitine (100 mg/kg, i.p.), starting at the same time as the glycerol injection; group 4 was given glycerol plus L-carnitine (100 mg/kg, i.p.), starting 48h before the glycerol injection. After glycerol injections, the i.p. injections of L-carnitine were repeated every 24h for four days. Ninety-six hours after glycerol injections, blood samples and kidney tissues were taken from the anesthetized rats. Urea and creatinine levels in plasma, N-acetyl-beta-D-glucosaminidase activity in urine, and malondialdehyde levels and catalase enzyme activity in kidney tissue were determined. Histopathological changes and iron accumulation in the kidney tissue were evaluated. In this study, glycerol administration led to marked renal oxidative stress, as well as severe functional and morphological renal deterioration. L-carnitine, possibly via its antioxidant properties, ameliorates glycerol-induced myoglobinuric kidney injury.
Assuntos
Injúria Renal Aguda/tratamento farmacológico , Carnitina/uso terapêutico , Mioglobinúria/complicações , Complexo Vitamínico B/uso terapêutico , Animais , Glicerol/toxicidade , Rim/metabolismo , Rim/patologia , Masculino , Malondialdeído/metabolismo , Mioglobinúria/induzido quimicamente , Estresse Oxidativo , Ratos , Ratos Sprague-DawleyRESUMO
OBJECTIVE: To study the clinical therapeutic effect of antioxidants assistant treatment of extremities crush syndrome (CS)in order to find new therapy. METHODS: Twenty-one male patients (aged from 24 to 48 years, mean 36 years) were treated with the next antioxidants in early stage: (1) 20% Mannitol 250 ml intravenous drip in 30 minutes (one time per 6 to 8 h). (2) Sodium aescinate 20 mg, Salvia Miltiorrhiza 20 ml were dissolved respectively in isotonic saline or 5% glucose 200 ml and dripped by intravenous drip (50 to 60 drips per minute). The drugs were used for 5 to 7 days (one time per day). Basifying urine, keeping the nagative liquid banlance and electrolyte banlance, preventing infection and hold out treatment were done. When the pressure of muscular osteofascial compartment was more than 30 mmHg, deep fasia was cut to decompress timely and the above-mentioned drugs were continuously applied for patients. RESULTS: Myoglobin urine of 21 cases died out after 2 to 3 days, of them, 13 cases were performed to decompress. After open decompression, 2 cases suffered from amputation because of long time of ischemia, 2 cases took place slight dysfunction of lower limbs, one hand had ischemia muscular contracture in 1 case and one foot down-vertical in 1 case. After followed-up of 8 months to 1 year, according to the function standard, the result were excellent in 8 cases, good in 7 cases, fair in 2 cases, poor in 4 cases. The excellent and good rate was about 71.4% (15/21). CONCLUSION: After extremities crushed for long time, application of antioxidents as early as possible can decrease significantly the incidence and invalidity rate of CS.
Assuntos
Antioxidantes/uso terapêutico , Síndrome de Esmagamento/tratamento farmacológico , Extremidades/lesões , Adulto , Antioxidantes/administração & dosagem , Síndrome de Esmagamento/complicações , Síndrome de Esmagamento/fisiopatologia , Síndrome de Esmagamento/urina , Humanos , Masculino , Pessoa de Meia-Idade , Mioglobinúria/complicações , Mioglobinúria/urina , Adulto JovemRESUMO
<p><b>OBJECTIVE</b>To study the clinical therapeutic effect of antioxidants assistant treatment of extremities crush syndrome (CS)in order to find new therapy.</p><p><b>METHODS</b>Twenty-one male patients (aged from 24 to 48 years, mean 36 years) were treated with the next antioxidants in early stage: (1) 20% Mannitol 250 ml intravenous drip in 30 minutes (one time per 6 to 8 h). (2) Sodium aescinate 20 mg, Salvia Miltiorrhiza 20 ml were dissolved respectively in isotonic saline or 5% glucose 200 ml and dripped by intravenous drip (50 to 60 drips per minute). The drugs were used for 5 to 7 days (one time per day). Basifying urine, keeping the nagative liquid banlance and electrolyte banlance, preventing infection and hold out treatment were done. When the pressure of muscular osteofascial compartment was more than 30 mmHg, deep fasia was cut to decompress timely and the above-mentioned drugs were continuously applied for patients.</p><p><b>RESULTS</b>Myoglobin urine of 21 cases died out after 2 to 3 days, of them, 13 cases were performed to decompress. After open decompression, 2 cases suffered from amputation because of long time of ischemia, 2 cases took place slight dysfunction of lower limbs, one hand had ischemia muscular contracture in 1 case and one foot down-vertical in 1 case. After followed-up of 8 months to 1 year, according to the function standard, the result were excellent in 8 cases, good in 7 cases, fair in 2 cases, poor in 4 cases. The excellent and good rate was about 71.4% (15/21).</p><p><b>CONCLUSION</b>After extremities crushed for long time, application of antioxidents as early as possible can decrease significantly the incidence and invalidity rate of CS.</p>
Assuntos
Adulto , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Antioxidantes , Usos Terapêuticos , Síndrome de Esmagamento , Tratamento Farmacológico , Urina , Extremidades , Ferimentos e Lesões , Mioglobinúria , UrinaRESUMO
1. Muscle injury (rhabdomyolysis) is one of the causes of acute renal failure (ARF). Iron, free radicals and nitric oxide (NO) play a critical role in the pathogenesis of glycerol-induced myoglobinuric ARF. L-Carnitine is an anti-oxidant and prevents the accumulation of end-products of lipid peroxidation. Therefore, the aim of the present study was to investigate the effects of L-carnitine on myoglobinuric ARF induced by intramuscular (i.m.) hypertonic glycerol injection. 2. Sprague-Dawley rats were divided into three groups. Rats in group 1 (n = 8) were given saline, whereas those in groups 2 (n = 10) and 3 (n = 10) were injected with glycerol (10 mL/kg, i.m.). Concomitant with and 24 h after glycerol injection, L-carnitine (200 mg/kg, i.p.) was administered to group 3 rats. Forty-eight hours after glycerol injection, blood samples and kidney tissues were taken from anaesthetised rats. 3. Plasma creatine kinase (CK) activity, urea, creatinine and NO levels, as well as kidney tissue superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) enzyme activity and malondialdehyde (MDA) and glutathione (GSH) levels, were determined. In the kidney tissue, histopathological changes and iron accumulation in the tubular epithelium were also investigated. 4. Glycerol treatment caused severe ARF: a marked renal oxidative stress, significantly increased CK activity, urea and creatinine levels and decreased plasma NO levels. Histopathological findings in group 2 rats confirmed that there was renal impairment by cast formation and tubular necrosis and a marked increase in iron accumulation in the tubular epithelium. All these factors were significantly improved by L-carnitine supplementation. 5. These results may indicate that L-carnitine treatment protects against functional, biochemical and morphological damage and iron accumulation in glycerol-induced myoglobinuric ARF in rats. In this model, the protective effect of L-carnitine treatment may provide a new insight into the treatment of rhabdomyolysis-related ARF.
Assuntos
Injúria Renal Aguda/prevenção & controle , Carnitina/farmacologia , Injúria Renal Aguda/sangue , Injúria Renal Aguda/induzido quimicamente , Animais , Carnitina/administração & dosagem , Catalase/metabolismo , Creatina Quinase/sangue , Feminino , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Glicerol/administração & dosagem , Glicerol/toxicidade , Injeções Intramusculares , Injeções Intraperitoneais , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Malondialdeído/metabolismo , Mioglobinúria/induzido quimicamente , Óxido Nítrico/sangue , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/metabolismo , Ureia/sangue , Complexo Vitamínico B/administração & dosagem , Complexo Vitamínico B/farmacologiaRESUMO
This paper systematically reviews the clinical evidence relating to the safety of extracts of the herbal anxiolytic kava (Piper methysticum). Literature searches were conducted in four electronic databases and the reference lists of all papers located were checked for further relevant publications. Information was also sought from the spontaneous reporting schemes of the WHO and national drug safety bodies and ten manufacturers of kava preparations were contacted. Data from short-term post-marketing surveillance studies and clinical trials suggest that adverse events are, in general, rare, mild and reversible. However, published case reports indicate that serious adverse events are possible including dermatological reactions, neurological complications and, of greatest concern, liver damage. Spontaneous reporting schemes also suggest that the most common adverse events are mild, but that serious ones occur. Controlled trials suggest that kava extracts do not impair cognitive performance and vigilance or potentiate the effects of central nervous system depressants. However, a possible interaction with benzodiazepines has been reported. It is concluded that when taken as a short-term monotherapy at recommended doses, kava extracts appear to be well tolerated by most users. Serious adverse events have been reported and further research is required to determine the nature and frequency of such events.
Assuntos
Ansiedade/tratamento farmacológico , Kava/efeitos adversos , Extratos Vegetais/efeitos adversos , Ansiolíticos/farmacologia , Doença Hepática Induzida por Substâncias e Drogas , Interações Medicamentosas , Etanol/farmacologia , Humanos , Mioglobinúria/induzido quimicamente , Doenças do Sistema Nervoso/induzido quimicamente , Testes Neuropsicológicos , Fitoterapia , Extratos Vegetais/farmacologia , Plantas Medicinais/efeitos adversos , Vigilância de Produtos Comercializados , Desempenho Psicomotor , Ensaios Clínicos Controlados Aleatórios como Assunto , Dermatopatias/induzido quimicamente , Sono/efeitos dos fármacosRESUMO
Myoglobin has a relatively high molecular weight of 17,000 Da and is poorly cleared by dialysis (diffusion). However, elimination of myoglobin might be enhanced by an epuration modality based on convection for solute clearances. We present a single case of myoglobin-induced renal failure (peak creatine kinase level: 313,500 IU/l) treated by continuous venovenous hemofiltration (CVVH). Our purpose was to evaluate the efficiency of such a modality using an ultrafiltration rate of 2 to 3 l/h for myoglobin removal and clearance. The hemofilter was a 0.9 m(2) polyacrylonitrile (AN69) membrane Multiflow-100 (Hospal-Gambro, St-Leonard, Canada) and the blood flow rate was maintained at 150 ml/min by an AK-10 pump (Hospal-Gambro, St-Leonard, Canada). The ultrafiltration bag was placed 60 cm below the hemofilter and was free of pump control or suction device. Serum myoglobin concentration was 92,000 microg/l at CVVH initiation and dropped to 28,600 microg/l after 18 h of the continuous modality. The mean sieving coefficient for myoglobin was 0.6 during the first 9 h of therapy and this decreased to 0.4 during the following 7 h. Mean clearance of myoglobin was 22 ml/min, decreasing to 14 ml/min during corresponding periods, while the mean ultrafiltration rates were relatively stable at 2,153 +/- 148 ml/h and 2,074 +/- 85 ml/h, respectively. In contrast to myoglobin, the sieving coefficeint for urea, creatinine, and phosphorus remained stable at 1.0 during the first 16 h of CVVH. More than 700 mg of myoglobin were removed by CVVH during the entire treatment. In conclusion, considerable amounts of myoglobin can be removed by an extracorporeal modality allowing important convective fluxes and middle molecule clearances, such as CVVH at a rate of 2 to 3 l/h using an AN69 hemofilter. If myoglobin clearance had been maintained at 22 ml/min, 32 l of serum would have been cleared per day. However, the sieving coefficient of myoglobin decreased over time, probably as a consequence of protein coating and/or blood clotting of the hemofilter. Whereas myoglobin can be removed by CVVH, it remains unknown at this point if such a modality, applied early, can alter or shorten the course of myoglobinuric acute renal failure.
Assuntos
Injúria Renal Aguda/etiologia , Injúria Renal Aguda/terapia , Hemofiltração/métodos , Mioglobina/sangue , Mioglobina/farmacocinética , Mioglobinúria/complicações , Rabdomiólise/complicações , Resinas Acrílicas , Injúria Renal Aguda/metabolismo , Adulto , Creatinina/sangue , Desidratação/complicações , Diabetes Mellitus Tipo 2/complicações , Hemofiltração/instrumentação , Humanos , Masculino , Taxa de Depuração Metabólica , Peso Molecular , Mioglobina/química , Mioglobinúria/metabolismo , Fósforo/sangue , Rabdomiólise/metabolismo , Sepse/complicações , Fatores de Tempo , Resultado do Tratamento , Ureia/sangueRESUMO
OBJECTIVE: The adult onset metabolic myopathy of carnitine palmitoyl transferase II (CPT II) deficiency is under-recognized, in part due to variable degrees of enzyme deficiency and symptomatology, as well as limitations in means for noninvasive evaluation. We describe a proton magnetic resonance spectroscopy (MRS) technique, using a standard clinical magnetic resonance imaging scanner, to diagnose and help monitor the response to therapy in adult CPT II deficiency. METHODS: A 53-year-old woman presented with a long standing history of diffuse aching and fatigue provoked by high fat intake, fasting, or prolonged exertion. Muscle biopsy revealed myopathic features and a deficiency (33% of control) of CPT II activity with elevated palmitoyl carnitine. Proton MRS of the soleus muscle was performed using a 1.5 Tesla scanner before and during dietary therapy. RESULTS: Proton MRS revealed shortening of the transverse relaxation time (T2), consistent with increased acetylation of the carnitine pool. The symptoms resolved completely by treatment with frequent feedings of a high carbohydrate diet low in long chain fatty acids supplemented with medium chain triglycerides and L-carnitine. Recovery of normal muscle MRS and carnitine T2 relaxation was documented by the third month of therapy. CONCLUSION: Proton MRS is a novel, potentially useful, and readily available adjunct in the diagnosis and therapeutic monitoring of muscle CPT II deficiency.
Assuntos
Carnitina O-Palmitoiltransferase/deficiência , Doenças Musculares/enzimologia , Adulto , Idade de Início , Biomarcadores , Carnitina/análogos & derivados , Carnitina/metabolismo , Carnitina O-Palmitoiltransferase/metabolismo , Fadiga/etiologia , Feminino , Humanos , Espectroscopia de Ressonância Magnética , Músculos/enzimologia , Músculos/metabolismo , Doenças Musculares/diagnóstico , Doenças Musculares/metabolismo , Mioglobinúria/etiologiaRESUMO
Following isolated limb perfusion (ILP) with TNF alpha and melphalan the damage to muscle tissue and its systemic consequences in terms of myoglobinemia and myoglobinuria as well as the activation of the cytokine cascade were investigated. We measured the compartmental pressure of the limb during and after perfusion and determined the serum changes of myoglobin, creatine kinase (CK), interleukin (IL)-6, IL-1, s-IL-2-receptor, TNF-receptor, and ICAM-1 levels. The compartmental pressure rose significantly during ILP and decreased after reperfusion. Following its course, the decision whether to perform a fasciotomy or not can be more reliably made. Serum myoglobin levels exceeded 200 times normal values and the increase occurred significantly earlier than that of CK, thus enabling judgement of the risk of renal failure (crush kidney syndrome). The elevation of serum IL-1 and IL-6 values correlated with the frequency of cardiopulmonary problems (hyperdynamic shock) and facilitated counter-maneuvers. Our data, although obtained from ILP with TNF alpha, could be used to monitor toxicity also when other drug regimens are administered.
Assuntos
Antineoplásicos Alquilantes/efeitos adversos , Quimioterapia do Câncer por Perfusão Regional , Extremidades , Hipertermia Induzida , Melanoma/terapia , Melfalan/efeitos adversos , Recidiva Local de Neoplasia/terapia , Sarcoma/terapia , Neoplasias Cutâneas/terapia , Neoplasias de Tecidos Moles/terapia , Fator de Necrose Tumoral alfa/efeitos adversos , Adolescente , Adulto , Idoso , Antineoplásicos Alquilantes/administração & dosagem , Terapia Combinada , Síndromes Compartimentais/sangue , Síndromes Compartimentais/induzido quimicamente , Citocinas/sangue , Feminino , Seguimentos , Humanos , Masculino , Melfalan/administração & dosagem , Pessoa de Meia-Idade , Mioglobina/sangue , Mioglobinúria/sangue , Mioglobinúria/induzido quimicamente , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/efeitos adversos , Rabdomiólise/sangue , Rabdomiólise/induzido quimicamente , Fator de Necrose Tumoral alfa/administração & dosagemAssuntos
Ácidos Graxos Dessaturases/deficiência , Erros Inatos do Metabolismo/diagnóstico , Mioglobinúria/etiologia , Acil-CoA Desidrogenase de Cadeia Longa , Idade de Início , Carnitina , Criança , Dieta , Feminino , Alimentos Fortificados , Humanos , Erros Inatos do Metabolismo/complicações , Erros Inatos do Metabolismo/terapia , Mioglobinúria/terapia , RecidivaRESUMO
This article presents a brief description of what is known about the cause and pathogenesis of chronic intermittent rhabdomyolysis in horses. Clinically applicable diagnostic tests and published results in affected horses, prophylaxis, and treatment of the acute case are discussed.